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Background. Sevoflurane or propofol–remifentanil-based anaesthetic regimens represent
modern techniques for neurosurgical anaesthesia. Nevertheless, there are potential differences
related to their activity on the cerebrovascular system. The magnitude of such difference is not
completely known.
Methods. In total 40 patients, treated for spinal or maxillo-facial disorders, were randomly
allocated to either i.v. propofol–remifentanil or inhalational sevoflurane anaesthesia. Transcranial
Doppler was used to assess changes in cerebral blood flow velocity, carbon dioxide reactivity,
cerebral autoregulation and the bispectral index to assess the depth of anaesthesia.
Results. Time-averaged mean flow velocity (MFV) was significantly reduced after induction of anaes-
thesia in both sevoflurane and propofol–remifentanil groups (P<0.001). At deeper levels of anaesthesia,
MFV increased in the sevoflurane group, suggesting an uncoupling flow/metabolism, whereas it was
further reduced in the propofol–remifentanil group (P<0.001). Indices of cerebral autoregulation were
reduced in patients with high-dose sevoflurane whereas autoregulation was preserved in patients
anaesthetized with propofol–remifentanil (P<0.001). Higher CO2 concentrations impaired cerebral
autoregulation in the sevoflurane group but not in patients anaesthetized with propofol–remifentanil.
Conclusions. Propofol–remifentanil anaesthesia induced a dose-dependent low-flow state with
preserved cerebral autoregulation, whereas sevoflurane at high doses provided a certain degree
of luxury perfusion.
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Sevoflurane and propofol are widely used as anaesthetic
agents for neurosurgery and demonstrate similar charac-
teristics for anaesthetic induction, maintenance, emergence
time and early cognitive function.1 2 Sevoflurane is currently
considered the inhalational agent of choice in neuroanaes-
thesia. Despite being less evident when compared with
other halogenated anaesthetics, sevoflurane demonstrated
an intrinsic cerebral vasodilatory effect, with a dose-
dependent increase in cerebral blood flow and similar
decrease in cerebrovascular resistance.3 4
Propofol has been recommended as an ideal hypnotic
during neurosurgical procedures. It is not associated
with significant modification of cerebral haemodynamics.5
It can be used in total intravenous anaesthesia (TIVA) in
association with remifentanil, an ultra-short-acting
mu-opioid receptor agonist. Target-controlled infusion
(TCI) of propofol–remifentanil allows for titration of the
hypnotic–analgesic effect along with rapid recovery and
early assessment of postoperative neurological function.6
Despite the fact that sevoflurane and propofol–
remifentanil based anaesthesia represent modern techniques
for neurosurgery, they display potential differences related
to the effects on the cerebrovascular system.1–4 7 8 The
magnitude of such differences is not completely known.
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In this study, two different anaesthetic techniques,
propofol–remifentanil TCI and sevoflurane inhalation
anaesthesia, were compared regarding changes in cerebral
blood flow velocity, carbon dioxide reactivity, and cerebral
autoregulation in a prospective randomized manner.
Transcranial Doppler (TCD) was used to obtain data
regarding changes in cerebral haemodynamics.
Methods
The study was designed to have an 80% chance of detecting
a 20% difference between the two groups at the two-sided
5% level, with an assumed SD of 30% in the outcome
variables. Two treatment groups of 20 patients each were
required. After approval had been obtained from the local
Ethics Committee, patients classified as ASA I or II, age
ranging from 18 to 65 yr and undergoing routine spinal and
oral–maxillo–facial surgical procedures, were recruited into
the study. Written informed consent was obtained from all
the patients.
Patients with intracranial pathological conditions were
excluded. Also patients with a history of cerebral, cardiac
or systemic vascular disorders, or those receiving medi-
cations that might influence the cerebrovascular function
were excluded. Preoperative duplex imaging of the vessels
in the neck was performed to detect any pathological
finding.
No pre-anaesthetic medication was administered to any
patient. The study was conducted in four stages, and all
the stages were completed before patient’s positioning for
surgical treatment.
In the first stage, awake patients were placed in supine
position and the bispectral index (BIS) (BIS XP monitor,
Aspect Medical Systems, Nantick, MA) was monitored.
Mean arterial blood pressure (MAP), heart rate, oxygen
saturation and end-tidal carbon dioxide were obtained
using the Julian anaesthesiology workstation, which was
connected to the monitoring unit (Vitara PM 8060, Dra¨ger,
Lu¨beck, Germany). The TCD probes were fixed in place
by applying a headband to maintain a constant angle of
insonation. Two baseline measurements of TCD variables
in awake patients, with BIS values of 90–100, were
performed.
In the second stage of the study, anaesthesia was induced
using a TCI of propofol (2.5–3.5 mg ml1) followed by
cisatracurium (0.15–0.2 mg kg1) and subsequent tracheal
intubation. After induction of anaesthesia, the patients were
placed on a mechanical ventilation system (Julian
Anesthesiology Workstation; Dra¨ger, Lu¨beck, Germany)
with an air and oxygen mixture (FIO2 0.4). Then, patients
were allocated to one of two different treatment groups
using random numbers generated by a computer software
program available online (www.graphpad.com/quickcalcs/
randomization1.cfm).
In the first group of patients (Group TIVA), anaesthesia
was maintained with remifentanil 0.15–0.25 mg kg1 min1
and TCI of propofol using Terufusion Syringe Pumps
TE-371 and TE-372 (TERUMO Europe, Leuven, Belgium)
titrated to achieve BIS values of 50 (5). In the second group
of patients (Group SEVO), anaesthesia was maintained with
sevoflurane titrated to achieve BIS values of 50 (5). In this
way, both groups had comparable levels of anaesthesia.
The TCD probes were repositioned in case a displacement
occurred during the preliminary stage, and examination was
started in all patients after 15 min of stable BIS values during
anaesthesia maintenance. This interval turned out to be neces-
sary also to achieve an adequate diffusion of sevoflurane, and
to obtain, in the patients maintained with sevoflurane, a pre-
dicted propofol concentration of <1.5–2 mg ml1, a concen-
tration that is presumed to have minimal effects on cerebral
haemodynamics.9 MAP was maintained within 10% of the
pre-induction values by administration of crystalloids, whereas
heart rate was maintained by use of atropine, if required.
Because of the potential influence of crystalloids on TCD
measurements, the infusion was given slowly, and examination
delayed until the MAP returned to pre-induction values. If an
excessive crystalloid infusion was needed, or if MAP could not
be maintained, the patient was excluded from the study.
End-tidal carbon dioxide was also maintained within 10%
of the initial values [4.7 (0.4) kPa]. The second series of
TCD examinations was performed in both groups of patients.
In the third stage of the study, in 20 patients (Group TIVA),
TCI of propofol associated with remifentanil was titrated to
achieve BIS values of 35 (2). In the remaining 20 patients
(Group SEVO), the concentration of sevoflurane was increased
to achieve similar BIS values. The third series of TCD
measurements was performed after 15 min to allow sufficient
time for equilibrium to be reached in both the groups.
In the fourth stage of the study, ventilation parameters
were changed by changing the ventilatory frequency with a
constant tidal volume in both groups to obtain an end-tidal
carbon dioxide of 6.0 (0.4) kPa. A supplementary series of
TCD examinations was obtained to evaluate carbon dioxide
reactivity and autoregulation at a different carbon dioxide
concentration. Such parameters were maintained until MAP,
which usually tended to increase at the beginning of hyper-
capnic challenge, returned within the range selected in
the study protocol (greater or lesser than 10% of the
basal values).
Transcranial Doppler ultrasonography
The middle cerebral artery (MCA) was insonated bilaterally
through the temporal window by using two pulsed 2-MHz
TCD ultrasound probes (Explorer CVS; Diagnostic Medical
System, Perols, France). Identification of the MCA flow
velocity was confirmed using standard criteria, at a depth
of 45–55 mm.10 The transient hyperaemic response test was
performed in a manner described in previous studies.9 11–14
The test is used to assess the hyperaemic response of MCA
blood flow velocity after a brief (5–9 s) compression of
the ipsilateral common carotid artery. It was considered
Conti et al.
334
 at Sistem
a Bibliotecario - U
niversitÃ  degli Studi di Palermo on June 20, 2012
http://bja.oxfordjournals.org/
D
ow
nloaded from
 
reliable when the following occurred: (i) compression of the
common carotid artery caused a sudden and maximum
decrease in flow velocity; (ii) stability of the heart rate
and signal power during the test; and (iii) compression las-
ting between 5 and 9 s.
Four tests were performed at each stage of the study,
alternating the two MCAs. Systolic flow velocity was cal-
culated using the mean value of systolic peaks from five
heart cycles, ending with the one preceding compression.
The hyperaemic response was calculated using the mean
systolic value of two heart cycles after compression release,
with the exception of the very first cycle (Fig. 1).
The values of all tests were averaged, obtaining two
values for each stage: FV1, defined as the mean basal
MCA systolic flow velocity; and FV3, defined as the
mean hyperaemic MCA systolic flow response.
As an index of the actual changes in cerebral blood flow
during the four different test series of the study (Awake, BIS
50, BIS 35, Hypercapnia), we recorded the time-averaged
mean flow velocity (MFV) in both the TIVA and sevo-
flurane groups. The values obtained were indicated as
MFVawake, MFV50, MFV35, or MFVhypercapnia. The
changes in MFV, taken to represent changes in cerebral
blood flow (CBF) at different stages were calculated as
DCBF50=MFVawakeMFV50; DCBF35=MFV50MFV35;
DCBFCO2=MFVnormocapniaMFVhypercapnia.
The transient hyperaemic response ratio (THRR), repre-
senting the hyperaemic response, was taken as the index of
autoregulation, and was calculated as THRR=FV3/FV1.
To assess the quality of the test, the magnitude of
the decrease in the flow velocity during compression, the
compression ratio (CR) was calculated as CR% =
(FV1FV2)·(100/FV1), where FV2 is defined as the
mean MCA flow velocity immediately after compression.
Statistical analysis
Comparisons between the groups regarding MAP, heart rate
and end-tidal carbon dioxide during different stages of the
study were made using one-way ANOVA with the Bonferroni
post hoc correction. Baseline MFV, FV1 and THRR were
compared using the Student’s t-test with the Welch
correction. The Wilcoxon matched-pairs test was used to
compare within-group changes in MFV and THRR during
different stages of the study. The unpaired Student’s t-test
was used to compare the changes between the groups. We
used a computer software program (INSTAT, version 3.0,
GRAPHPAD, San Diego, CA) to perform statistical
analysis. P<0.05 was considered statistically significant.
All values are reported as mean (SD).
Results
In all, 46 patients were recruited. Four patients, in the
sevoflurane group, were subsequently excluded because
of protocol violation as sympathetic stimulant drugs and/
or large amount of crystalloids had to be administered to
maintain MAP. Two patients, one in each group, were
excluded because of bradycardia after carotid compression.
Because of the patients’ withdrawal, after the first
30 patients, who were randomized in equal proportion, a
block randomization was continued allocating patients in
proportion of 2 in the sevoflurane to 1 in the TIVA group.
Analysis was restricted only to the participants who
completed the study protocol. A total of 40 patients,
23 men and 17 women completed the study. The
characteristics of patients are shown in Table 1.
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Fig 1 The transient hyperaemic response test. After carotid artery compression the systolic flow velocity (FV1) in middle cerebral artery (MCA)
decreased abruptly. After compression release, the systolic flow velocity (FV3) increased over baseline values, showing the typical hyperaemic
autoregulatory response. In order to calculate the hyperaemic response ratio, five heart cycles before compression and two after compression release
(arrows), excluding the very first, were used.
Table 1 Patient characteristics in the two groups. Data for age and weight
are mean (SD)
Group TIVA (n=20) Group SEVO (n=20)
Gender (male/female) 12/8 11/9
Age (yr) 44 (12) 43 (10)
Weight (kg) 67 (8) 65 (7)
Values are given as mean (SD).
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Table 2 summarizes values of physiological variables at
the different stages of the study. In awake patients MFV was
55.0 (8.6) cm s1 in Group SEVO and 54.3 (7.6) cm s1 in
Group TIVA (P>0.05).
In the second stage of the study, i.e. BIS 50, sevoflurane
concentration was 1.7 (0.4)% (Group SEVO), whereas
the TCI of propofol was at 2.7 (0.5) ml ml1, and remi-
fentanil was administered at 0.18 (0.06) mg kg1 min1
(Group TIVA). Sevoflurane reduced MFV to 42.4
(8.2) cm s1 (P<0.001), and TIVA reduced it to 37.3
(12.1) cm s1 (P<0.001). The change (DCBF50) was
significantly different between the groups (P<0.05).
At the third stage of the study, i.e. at BIS 35, the
sevoflurane concentration was increased to 2–4% in
Group SEVO, whereas the TCI of propofol was at
3.1 (0.6) ml ml1 and remifentanil was administered at
0.20 (0.07) mg kg1 min1 in Group TIVA. High doses
of sevoflurane increased MFV to 50.3 (11.4) cm s1 whereas
TIVA, at equipotent anaesthetic doses, decreased MFV to
32.9 (9.1) cm s1 (P<0.001) (Fig. 2). These data suggested
an uncoupling flow/metabolism in Group SEVO (Fig. 3).
In awake patients, THRR was 1.21 (0.06) in Group SEVO
and 1.23 (0.09) in Group TIVA, and after induction of
anaesthesia, at BIS 50, the values were 1.22 (0.1) and
1.27 (0.2), respectively; the values were not statistically
different. At BIS 35, in Group TIVA, the THRR increased
to 1.36 (0.2), whereas in Group SEVO it decreased to 1.10
(0.1) (P<0.001), indicating a tendency for impaired cerebral
autoregulation during high-dose sevoflurane anaesthesia
(Fig. 4).
In the last stage of the study, in both groups of patients,
ventilation parameters were changed to achieve end-tidal
carbon dioxide of 6 kPa. On average 5 min were required
for MAP, which usually tended to increase at the beginning
of hypercapnia, to return within the range selected in the
study protocol (greater or lesser than 10%). MFV increased
in both groups, from 50.3 (11.4) to 56.1 (11.5) cm s1 in
Group SEVO, and from 32.9 (9.1) to 39.1 (7.4) cm s1 in
Group TIVA; the THRR was 1.07 (0.04) in Group SEVO
and 1.22 (0.13) in Group TIVA (P<0.001) (Fig. 4).
Discussion
Our data suggest that the TIVA with propofol–remifentanil
induces a low-flow state preserving the pressure-flow
autoregulation whereas high doses of sevoflurane adminis-
tration may cause a certain degree of luxury perfusion.
Both sevoflurane and propofol-based anaesthetic regi-
mens represent modern techniques for neurosurgical anaes-
thesia. Haemodynamic properties of these agents have been
widely analysed. Nevertheless, the influence of combining
Table 2 Summary of physiological variables in the two groups during the
different stages of the study
Group MAP
(mm Hg)
Heart rate
(beats min1)
End-tidal
CO2 (kPa)
Temperature
(C)
Awake SEVO 85 (7) 73 (8) 4.7 (0.4) 36.8 (0.2)
TIVA 85 (8) 75 (10) 4.7 (0.4) 36.8 (0.2)
BIS 50 SEVO 78 (6) 76 (7) 4.7 (0.4) 36.8 (0.2)
TIVA 77 (7) 79 (7) 4.7 (0.4) 36.8 (0.2)
BIS 35 SEVO 73 (6) 77 (5) 4.7 (0.4) 36.7 (0.2)
TIVA 74 (7) 81 (7) 4.7 (0.4) 36.7 (0.2)
Hypercapnia SEVO 76 (5) 77 (5) 6.0 (0.4) 36.8 (0.2)
TIVA 75 (5) 80 (5) 6.0 (0.4) 36.7 (0.2)
Values are given as mean (SD). BIS 50, BIS 35 and Hypercapnia are
the stages of study during anaesthesia at BIS value of 50, 35 and
with hypercapnia, respectively. Differences between the groups were
insigniﬁcant.
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Fig 2 Bar graph showing changes in mean flow velocity (MFV)
recorded on the MCA during the different stages of the study. Changes
in MFV were used as indices of actual changes in cerebral blood flow
(CBF). DCBFBIS50 represents the difference between MFV values
recorded in awake patients and after induction of anaesthesia and at
bispectral index (BIS) value of 50. DCBFBIS35 represents the average
change in MFV in patients from a BIS value of 50 to a BIS value of
35. DCBFhyperCO2 represents the average change in MFV in patients
hypoventilated to an end-tidal CO2 of 6 kPa and at BIS of 35. Error
bars indicate SD. *P<0.05; ***P<0.001 between groups.
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Fig 3 MFV in awake patients, after induction of anaesthesia (BIS 50)
and during deep anaesthesia (BIS 35). In Group TIVA, the MFV
decreased progressively with the decrease of the cerebral electric
activity as measured using BIS. In Group SEVO, higher doses caused
an increase of the MFV despite a decreased BIS value, indicating an
uncoupling between the metabolic demand and blood flow. Error bars
indicate SD.
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propofol–remifentanil on cerebrovascular haemodynamics
is relatively unknown.15 Furthermore, the difference
between these two anaesthetic regimens during deep anaes-
thesia or increased carbon dioxide concentration and equi-
potent anaesthetic concentrations has not been determined.
Previous information on propofol is quite coherent,
reductions in both cerebral metabolism and regional CBF
have been described.16 In our study, a graded and significant
reduction of MFV, when target doses were increased and
BIS values decreased, were recorded, suggesting a reduction
of flow along with neuronal activity during propofol–
remifentanil TIVA. However, whether propofol reduces
flow and metabolism in equivalent proportions still needs
to be determined.17–20
Sevoflurane also reduces regional cerebral metabolism,21
and the reduction is similar to that of propofol, which could
suggest that these drugs are actually equally potent sup-
pressors of neuronal metabolism. Regarding the flow
effects, sevoflurane at 1 MAC has been shown to reduce
regional CBF by 36–53% from awake values as a result of
reduced cerebral metabolism.7 Nevertheless, it has been
demonstrated that when administered during propofol
anaesthesia, namely in a state of depressed neuronal activity,
sevoflurane increased basal flow velocity in the MCA by 17
(3)% at 1.5 MAC.3 Furthermore, increasing sevoflurane
concentration from 1.5 to 2.5% in patients with supra-
tentorial tumour caused a certain degree of cerebral vaso-
dilation,22 and, in rats, 2.0 MAC sevoflurane abolished the
autoregulatory response to hypotension.23 These findings
suggest the presence of an intrinsic dose-dependent vas-
odilatory effect of sevoflurane, although this effect is less
than that reported for halothane, isoflurane and desflurane at
equipotent anaesthetic concentrations.24
The vasodilatory properties of sevoflurane are confirmed
by our data; at higher doses and deep anaesthesia, namely at
BIS values of 35, we have shown a certain degree of uncoup-
ling of flow-metabolism in patients with sevoflurane (Fig. 3).
The uncoupling of flow-metabolism as seen during use of
inhalational anaesthetic agents actually demonstrates that
cerebral vasodilation is a result of a direct action of these
agents on vascular smooth muscle. This may cause an
impairment of cerebral autoregulation.25 Cerebrovascular
autoregulation was therefore assessed in the two groups
of patients. Modelling of cerebral autoregulation using
the THR test has been performed, and details published
previously.9 11–14 Essentially, the decrease in MCA perfu-
sion pressure at the onset of carotid artery compression
provokes autoregulatory vasodilation in the MCA territory.
Release of compression allows perfusion pressure to
return to baseline but, because of the reduced resistance
of the vascular bed, flow velocity in the MCA overshoots
the baseline values (hyperaemic response).
In theory, the dose-dependent action of sevoflurane on
cerebral vascular resistance may reflect on cerebral auto-
regulation in a dose-dependent manner. Actually, it has been
shown that in healthy subjects with normal PaCO2 cerebral
autoregulation was preserved with 1.2 MAC22 and 1.5
MAC8 sevoflurane. During normocapnia, 1.5 MAC sevo-
flurane marginally affected dynamic autoregulation in
response to rapid deflation of thigh cuffs.26 In a previous
study, we determined that the transient hyperaemic response
to carotid artery compression was preserved with 2 MAC
sevoflurane anaesthesia whereas it was impaired on adding
nitrous oxide. Nevertheless, the values of the hyperaemic
response recorded during sevoflurane anaesthesia were
lower than those recorded in normocapnic awake patients.11
In this study, it was recorded that when approximately
2 MAC sevoflurane concentrations were used, the hyper-
aemic response showed a tendency to reduce. Conversely,
during propofol–remifentanil anaesthesia, the autoregu-
latory index increased significantly. This suggests that
the low-flow state induced by propofol–remifentanil and
the increase of CVR probably widens the autoregulatory
plateau,27 whereas the intrinsic tendency of sevoflurane to
reduce cerebral vascular resistance has an opposite effect.
Our findings agree with a recent study that showed that
in anaesthetized patients undergoing cardiopulmonary
bypass, infusion of propofol could improve cerebral auto-
regulation that was previously impaired.28
Carbon dioxide strongly influences cerebral autoregula-
tion. Hypocapnia widens the plateau of the static pressure
autoregulation curve.29 The opposite effect is observed in
hypercapnia with an upward shift of the autoregulatory
curve and disappearance of the plateau at very high levels
of PaCO2 . Recently, however, Panerai
30 suggested that a
more realistic representation of the effects of carbon dioxide
are manifested as changes in the critical closing pressure
instead of changes in resistance with a shift of the pressure-
flow curve and only minor changes of the slope.
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Fig 4 Bar graph showing the changes in the hyperaemic response after
carotid artery compression during the different stages of the study.
Similar values were recorded in the two groups before induction of
anaesthesia. Low doses of both anaesthetic regimens (BIS 50) did not
change the hyperaemic response significantly. Higher doses of
sevoflurane reduced the hyperaemic response whereas higher doses of
propofol–remifentanil increased the hyperaemic response (BIS 35).
Increasing end-tidal carbon to 6 kPa abolished the hyperaemic response
in patients receiving sevoflurane, whereas a valid hyperaemic response
was still recorded in the propofol–remifentanil group. Error bars indicate
SD. TIVA (propofol–remifentanil total intravenous anesthesia); THRR
(transient hyperaemic response ratio). **P<0.001 between groups.
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Interestingly, at the same anaesthetic doses and levels of
anaesthesia as determined using BIS, an end-tidal carbon
dioxide of 6 kPa impaired autoregulation in patients receiv-
ing sevoflurane, but not propofol–remifentanil TIVA. It is of
note that an end-tidal carbon dioxide of 6 kPa is well within
the range commonly seen with spontaneous ventilation
during general anaesthesia.
The view that the opposite effects on cerebral vascular
resistance observed with the two anaesthetic regimens can
be translated into hyper- and hypo-regulatory states would
hold true only according to a single-parameter model.
Nevertheless, this cannot provide a realistic representation
of pressure-flow/velocity relationship of the cerebral auto-
regulation.30 In particular, autoregulation should be regarded
as a reflection of flow-metabolism coupling. Despite
conflicting results, there are studies demonstrating that pro-
pofol reduces CBF to a greater extent than it reduces
cerebral metabolism, indicating that propofol has direct
vasoconstricting properties. Jansen and colleagues19
found that in patients undergoing brain tumour surgery
there was a significantly lower jugular saturation in patients
anaesthetized with propofol than in a matched group anaes-
thetized with nitrous oxide and isoflurane; Nandate and
colleagues18 found a significant decrease in jugular bulb
saturation 1 h after normothermic cardiopulmonary bypass
with propofol anaesthesia but not with isoflurane or
sevoflurane anaesthesia. According to this view, the
low-flow state induced by propofol may ameliorate the
pressure-flow relationship, but worsen the flow-metabolism
ratio, so creating a disautoregulation instead of a hyper-
regulatory state.
How the luxury perfusion produced by sevoflurane and
the low-flow state determined by propofol–remifentanil
TIVA when administered at high doses may influence
clinical outcome still needs to be determined. Actually,
the low-flow state and the consequent reduced intracranial
pressure determined by propofol–remifentanil are signifi-
cantly advantageous for neurosurgery; however, an equiva-
lent reduction in cerebral metabolism with maintenance of
oxygen extraction fraction is paramount. Further studies
addressing this issue are therefore necessary.
Accordingly, even if caution in using high doses of
sevoflurane in patients with increased intracranial pressure
or at risk for inadequate brain relaxation can be suggested,
definitive and unequivocal data on the potential differences
in neuroprotective activity of the two studied anaesthetic
regimens are difficult to determine.
Finally, there are some considerations on the methods
used in this study. One advantage of this study is represented
by the effort to limit confounding factors, as much as pos-
sible. Pre-anaesthetic medications were not administered,
and sympathetic drugs, such as phenylephrine, were avoided
given the potential action on cerebral haemodynamics
during contemporaneous administration of volatile anaes-
thetic agents.31 Furthermore, instead of using qualitative
parameters to provide a reasonable certainty of ensuring
an equipotent hypnotic effect, neuronal depression and,
consequently, metabolic activity in the two groups of
patients, we used the BIS which has the advantage of not
requiring patient stimulation and of providing a quantitative
measure.32 In fact, several findings indicate that the use of
BIS may be a valuable guide for intraoperative adminis-
tration of propofol and sevoflurane.33 The use of this
monitoring device decreases consumption of both propofol
and sevoflurane and facilitates immediate recovery after
propofol anaesthesia, whereas intraoperative course is not
changed.33 BIS has been previously used to evaluate the
level of anaesthesia when comparing inhalational sevo-
flurane and i.v. propofol anaesthesia.34 BIS has been used
to keep a constant hypnotic depth throughout anaesthesia to
quantify the effects of sevoflurane and propofol on CBF,
metabolic rate of oxygen and blood volume using posi-
tron emission tomography.7 Boisseau and colleagues35
compared the effects of propofol and sevoflurane on cortical
somatosensory evoked potentials adjusting the anaesthetic
concentration to obtain a constant hypnotic depth by means
of the BIS.
On the other hand, a potential disadvantage of the study is
represented by the use of MFV as a surrogate measure of
changes in CBF. This is problematic because any change in
the diameter of the insonated vessel would alter the relation
between flow velocity and actual blood flow. However, it
was demonstrated by direct intraoperative measurement that
the MCA diameter does not change significantly during
variations in MAP or PaCO2 .
36 In the end, we accepted
only tests in which the power of the Doppler spectrum
remained constant. In fact, the acoustic intensity for each
velocity is proportional to the volume of blood moving at
that particular velocity and, thus, if the acoustic intensity
(i.e. the TCD waveform spectrum) remains constant, flow
velocities are linearly proportional to actual blood flow
within the vessel segment, suggesting that no change in
MCA diameter occurred.
In conclusion, propofol–remifentanil TIVA demonstrated
advantageous preservation pressure-flow relationship by
inducing a dose-dependent low-flow state, during deep
anaesthesia and higher end-tidal carbon dioxide concen-
trations. With sevoflurane, cerebral autoregulation was
preserved at lower concentrations; however, at higher
concentrations, it provided a degree of luxury perfusion
and impaired autoregulation with hypercapnia. Accord-
ingly, even if caution in using high doses of sevoflurane
in patients with increased ICP or at risk for inade-
quate brain relaxation can be suggested, definitive and
unequivocal data on the neuroprotective activity of the
two studied anaesthetic regimens still needs to be
determined.
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